Table 3.
Emerging drug-resistant microorganisms3
| Drug-resistant organisms | Year reported | Incidence rate in India |
|---|---|---|
| Methicillin-resistant Staphylococcus aureus (MRSA) | 19617 | 35.7% |
| Vancomycin intermediate Staphylococcus aureus (VISA) | 19968 | 0.1% |
| Vancomycin-resistant Staphylococcus aureus (VRSA) | 20029 | Few scattered reports |
| Vancomycin-resistant enterococci (VRE) | 198610 | 8.6% |
| Extended-spectrum beta-lactamase (ESBL) | 198311 | Escherichia coli: 83% |
| Klebsiella pneumoniae: 80% | ||
| Carbapenem-resistant Enterobacteriaceae (CRE) | 198012 | Escherichia coli: 18% |
| Klebsiella pneumoniae: 35% | ||
| Colistin-resistant gram-negative bacilli | 201513 | Enterobacteriaceae: 1% |
| Pseudomonas aeruginosa: 10% | ||
| Acinetobacter baumannii: 22% |